Literature DB >> 9918793

Alteration of HERG current profile during the cardiac ventricular action potential, following a pore mutation.

J C Hancox1, H J Witchel, A Varghese.   

Abstract

HERG is believed to encode the major sub-unit of the cardiac 'rapid' delayed rectifier K channel (I(Kr)). Both I(Kr) and HERG exhibit marked inward rectification at positive membrane potentials due to rapid inactivation and this is thought to influence significantly the contribution of the current to cardiac action potential (AP) repolarisation. We investigated directly the role played by rapid inactivation, by measuring current activated by a ventricular AP waveform, from Chinese Hamster Ovary cells transfected with HERG cDNA with a point-mutation (S631A) in the pore region. Square command pulses elicited HERG-S631A current which increased progressively in magnitude with test potential up to +30/+40 mV (n=6). During test pulses to +40mV, HERG-S631A exhibited little inactivation compared to wildtype HERG. During an action potential command, WT-HERG current developed progressively during the AP plateau and slow repolarisation phase, showing maximal current between -30mV and -40 mV (n=10). In contrast, HERG-S631A current increased earlier during the AP plateau, with a maximal amplitude near +30mV (n=7). Current then declined as the AP proceeded, giving rise to a 'bow'- or 'inverted-U-' shaped current profile. A mathematical model with inactivation removed from the HERG current reproduced the I-V profile of HERG-S631A. These data provide a direct demonstration that rapid inactivation normally plays a critical role in determining both time-course and voltage dependence of HERG/I(Kr) -current during the cardiac ventricular AP.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9918793     DOI: 10.1006/bbrc.1998.9837

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  8 in total

1.  Rate dependency of delayed rectifier currents during the guinea-pig ventricular action potential.

Authors:  M Rocchetti; A Besana; G B Gurrola; L D Possani; A Zaza
Journal:  J Physiol       Date:  2001-08-01       Impact factor: 5.182

2.  Pharmacology of the short QT syndrome N588K-hERG K+ channel mutation: differential impact on selected class I and class III antiarrhythmic drugs.

Authors:  M J McPate; R S Duncan; J C Hancox; H J Witchel
Journal:  Br J Pharmacol       Date:  2008-08-25       Impact factor: 8.739

3.  Protein kinase C enhances the rapidly activating delayed rectifier potassium current, IKr, through a reduction in C-type inactivation in guinea-pig ventricular myocytes.

Authors:  B M Heath; D A Terrar
Journal:  J Physiol       Date:  2000-02-01       Impact factor: 5.182

4.  Inhibition of HERG K+ current and prolongation of the guinea-pig ventricular action potential by 4-aminopyridine.

Authors:  J M Ridley; J T Milnes; Y H Zhang; H J Witchel; J C Hancox
Journal:  J Physiol       Date:  2003-05-09       Impact factor: 5.182

5.  Mechanistic insight into human ether-à-go-go-related gene (hERG) K+ channel deactivation gating from the solution structure of the EAG domain.

Authors:  Frederick W Muskett; Samrat Thouta; Steven J Thomson; Alexander Bowen; Phillip J Stansfeld; John S Mitcheson
Journal:  J Biol Chem       Date:  2010-12-06       Impact factor: 5.157

6.  Action potential clamp characterization of the S631A hERG mutation associated with short QT syndrome.

Authors:  Andrew Butler; Yihong Zhang; Alan G Stuart; Christopher E Dempsey; Jules C Hancox
Journal:  Physiol Rep       Date:  2018-09

7.  Phenanthrene impacts zebrafish cardiomyocyte excitability by inhibiting IKr and shortening action potential duration.

Authors:  Shiva N Kompella; Fabien Brette; Jules C Hancox; Holly A Shiels
Journal:  J Gen Physiol       Date:  2021-02-01       Impact factor: 4.086

8.  Identification through action potential clamp of proarrhythmic consequences of the short QT syndrome T618I hERG 'hotspot' mutation.

Authors:  Chunyun Du; Henggui Zhang; Stephen C Harmer; Jules C Hancox
Journal:  Biochem Biophys Res Commun       Date:  2022-01-21       Impact factor: 3.575

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.